JP Morgan Maintains Overweight on Healthcare Realty Trust, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Michael Mueller maintains an Overweight rating on Healthcare Realty Trust (NYSE:HR) but lowers the price target from $19 to $17.
March 06, 2024 | 4:12 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan maintains an Overweight rating on Healthcare Realty Trust but lowers the price target from $19 to $17.
The adjustment in price target by a major analyst like JP Morgan could have a mixed impact on HR's stock price. While maintaining an Overweight rating indicates a positive outlook, the reduction in price target could signal a tempered expectation for the stock's performance. Investors might react cautiously to this news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100